Therapeutic dilemmas with thalidomide in multiple myeloma: Case discussions

被引：5
作者：
Desikan, RK [1 ]
Jagannath, S [1 ]
机构：
[1] St Vincents Comprehens Canc Ctr, New York, NY 10011 USA
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 06期
关键词：
D O I：
10.1053/sonc.2001.28613
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：593 / 596
页数：4
相关论文
共 25 条
  • [1] Badros A, 2000, BLOOD, V96, p285B
  • [2] Total therapy with tandem transplants for newly diagnosed multiple myeloma
    Barlogie, B
    Jagannath, S
    Desikan, KR
    Mattox, S
    Vesole, D
    Siegel, D
    Tricot, G
    Munshi, N
    Fassas, A
    Singhal, S
    Mehta, J
    Anaissie, E
    Dhodapkar, D
    Naucke, S
    Cromer, J
    Sawyer, J
    Epstein, J
    Spoon, D
    Ayers, D
    Cheson, B
    Crowley, J
    [J]. BLOOD, 1999, 93 (01) : 55 - 65
  • [3] Bellamy WT, 1999, CANCER RES, V59, P728
  • [4] CHAPON F, 1985, REV NEUROL-FRANCE, V141, P719
  • [5] THALIDOMIDE NEUROTOXICITY
    CLEMMENSEN, OJ
    OLSEN, PZ
    ANDERSEN, KE
    [J]. ARCHIVES OF DERMATOLOGY, 1984, 120 (03) : 338 - 341
  • [6] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS
    DAMATO, RJ
    LOUGHNAN, MS
    FLYNN, E
    FOLKMAN, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4082 - 4085
  • [7] Desikan R, 1999, BLOOD, V94, p603A
  • [8] Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade
    Geitz, H
    Handt, S
    Zwingenberger, K
    [J]. IMMUNOPHARMACOLOGY, 1996, 31 (2-3): : 213 - 221
  • [9] HARLAND CC, 1995, EUR J CLIN PHARMACOL, V49, P1
  • [10] Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
    Hideshima, T
    Chauhan, D
    Shima, Y
    Raje, N
    Davies, FE
    Tai, YT
    Treon, SP
    Lin, B
    Schlossman, RL
    Richardson, P
    Muller, G
    Stirling, DI
    Anderson, KC
    [J]. BLOOD, 2000, 96 (09) : 2943 - 2950
123